Previous 10 | Next 10 |
2023-06-05 07:34:18 ET Prenetics Global press release ( NASDAQ: PRE ): Q1 GAAP EPS of -$0.07. Revenue of $17.7M (-80.8% Y/Y). For further details see: Prenetics Global GAAP EPS of -$0.07, revenue of $17.7M
HONG KONG, June 05, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading genomics and precision oncology company, today announced financial results for the first quarter ended March 31, 2023, along with recent busine...
Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results, New Business Strategy Focused on Precision Oncology LONDON AND HONG KONG, Mar 14, 2023 - (ACN Newswire) - Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading genomics and precision ...
2023-03-14 08:59:03 ET Prenetics Global press release ( NASDAQ: PRE ): Q4 GAAP EPS of $0.01. Revenue of $52.3M (-19.2% Y/Y). Gross margin was 51.6% for the fourth quarter 2022 compared to 36.7% for the fourth quarter 2021. Profit from operations was US$4.6 million ...
LONDON and HONG KONG, March 14, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading genomics and precision oncology company, today announced financial results for the fourth quarter and full year ended December 31, ...
LONDON and HONG KONG, March 02, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leader in genomic and diagnostic testing, is proud to announce the formation of a new Prenetics Scientific Advisory Board (the ‘SAB’) to provide strategic input based on their scientif...
LONDON and HONG KONG, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leader in genomic and diagnostic testing, today announced that its management team will participate virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference from ...
To ensure the company realizes the full potential of its broad genetics and digital testing platform and as a commitment to the EMEA market, Prenetics Globa ( NASDAQ: PRE ) names Dr. Bayju Thakar as CEO and shall join the board of directors for Prenetics EMEA, a wholly owned subsidiar...
LONDON and HONG KONG, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) a leader in genomic and diagnostic testing, today announced an executive leadership change to ensure the company realizes the full potential of its broad genetics and digital testing platform and as a c...
3 Ways That Penny Stocks Can Make You Money in 2023 Penny stocks can also be a great way to make money if done correctly. Before you invest in a penny stock, it is important to do research into the company and understand how their stock works. This means understanding the risks associated wit...
News, Short Squeeze, Breakout and More Instantly...
Prenetics Global Limited Company Name:
PRE Stock Symbol:
NASDAQ Market:
Prenetics Global Limited Website:
LOS ANGELES, July 01, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, welcomes Kathryn M. Henry and David Vanderveen as independent directors to the Company’s Board of Directors. ...
2024-06-27 05:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
--News Direct-- Cancer remains one of the most formidable challenges in modern medicine, claiming millions of lives each year. Early detection and personalized treatment have become critical in improving survival rates. In this context, the genomics and health sciences sectors are emerging as...